Anakinra as a Rescue Treatment for Allergic Inflammation

NCT04035109 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Study stopped due to COVID-19 pandemic.

Conditions

Asthma, Allergic

Interventions

DRUG: Anakinra
DRUG: Preservative-free 0.9% sodium chloride (Placebo)
BIOLOGICAL: House dust mite allergen
BIOLOGICAL: Cat hair allergen

Sponsor

University of North Carolina, Chapel Hill

Collaborators

[object Object]